Buscar
-
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.
(Cell. vol. 148, n° 5, pp. 1039-50, 2012-03-02)Article de revueLibre acceso -
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre acceso -
Vangl2 in the Dentate Network Modulates Pattern Separation and Pattern Completion
(Cell Reports. vol. 31, n° 10, pp. 107743, 2020-06-09)Article de revueLibre acceso -
Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-05)Article de revue -
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
(Cells. vol. 12, n° 15, pp. 1927, 2023-07-25)Article de revueLibre acceso -
Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample
(Drug and Alcohol Dependence. vol. 251, 2023-10-01)Article de revue -
Camkiiβ in neuronal development and plasticity: An emerging candidate in brain diseases
(International Journal of Molecular Sciences. vol. 21, n° 19, pp. 1-15, 2020-10-01)Article de revueLibre acceso -
Structural progression of Alzheimer's disease over decades: The MRI staging scheme
(Brain Communications. vol. 4, n° 3, 2022-04-28)Article de revueLibre acceso -
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment
(Neurology(R) neuroimmunology & neuroinflammation. vol. 10, n° 6, 2023-09-22)Article de revueLibre acceso -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueLibre acceso